Diabetes Care, Vol 21, Issue 5 792-795, Copyright © 1998 by American Diabetes Association

ARTICLES

Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes

CL Arfken, PL Reno, JV Santiago and R Klein
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. carfken@med.wayne.edu

OBJECTIVE: To investigate the comparable risk of developing proliferative diabetic retinopathy (PDR) in African-Americans and whites with type 1 diabetes. RESEARCH DESIGN AND METHODS: Using a cohort design with the sample drawn from medical records, the sample consisted of 312 people with type 1 diabetes (97 African-Americans, 215 whites) having at least two visits to a Model Demonstration Unit with gradeable fundus photographs (stereo, color, 7 standard fields). Excluded were subjects with preexisting or treated PDR or hemoglobinopathy. Masked grading of the fundus photographs was conducted at the Wisconsin Reading Center. RESULTS: At baseline, African-Americans had poorer glycemic control (mean HbA1 of 11.3 vs. 10.0%, P < 0.0001), higher systolic blood pressure (mean of 117 vs. 110 mmHg, P < 0.001), and were older (mean of 26.8 vs. 19.3 years, P < 0.0001) than the white subjects. African-Americans also tended to have slightly longer duration of diabetes and length of follow-up. In the African-Americans, 17.5% developed PDR, compared with 10.2% in the 215 whites, for an odds ratio (OR) of 1.86 (95% CI 0.93-3.70). When adjusted for baseline glycemic control, retinopathy grade, and length of follow-up, race was not a significant risk factor (OR = 0.73, 95% CI 0.30-1.78). CONCLUSIONS: African-Americans with type 1 diabetes may have a higher rate of developing PDR. The observed racial difference, however, is attributable to the presence of a worse risk factor profile, especially to poorer glycemic control. Efforts should be expanded to improve the care for all individuals with poor glycemic control.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Johns, M. S. Faulkner, and L. Quinn Characteristics of Adolescents With Type 1 Diabetes Who Exhibit Adverse Outcomes The Diabetes Educator, September 1, 2008; 34(5): 874 - 885. [Abstract] [Full Text] [PDF]

				M. S. Roy and M. Affouf Six-year progression of retinopathy and associated risk factors in african american patients with type 1 diabetes mellitus: the new jersey 725. Arch Ophthalmol, September 1, 2006; 124(9): 1297 - 1306. [Abstract] [Full Text] [PDF]

				M C Marshall Jr Diabetes in African Americans Postgrad. Med. J., December 1, 2005; 81(962): 734 - 740. [Abstract] [Full Text] [PDF]

				The Eye Diseases Prevalence Research Group Causes and Prevalence of Visual Impairment Among Adults in the United States Arch Ophthalmol, April 1, 2004; 122(4): 477 - 485. [Abstract] [Full Text] [PDF]

				M. B. Davidson Effect of Nurse-Directed Diabetes Care in a Minority Population Diabetes Care, August 1, 2003; 26(8): 2281 - 2287. [Abstract] [Full Text] [PDF]

				T Zolfino, M A Heneghan, S Norris, P M Harrison, B C Portmann, and I G McFarlane Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin Gut, May 1, 2002; 50(5): 713 - 717. [Abstract] [Full Text] [PDF]

				M. B. Davidson, V. J. Karlan, and T. L. Hair Effect of a Pharmacist-Managed Diabetes Care Program in a Free Medical Clinic American Journal of Medical Quality, July 1, 2000; 15(4): 137 - 142. [Abstract] [PDF]